Apollo Global Management Inc. is acquiring a minority equity interest in Sofinnova Partners, a European venture capital firm that invests in life sciences companies.
The alternative asset manager will commit as much as 1 billion euros ($1.04 billion) in managed capital to Sofinnova’s investment funds, according to a statement obtained by Bloomberg News.
Besides life sciences, Apollo has identified several areas including financial technology, and software, where it can find opportunities to partner with other funds. Under a similar model, it invested in fintech specialist Motive Partners last year.
Read more: BNN Bloomberg
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.